Venous and arterial thrombosis associated with abemaciclib therapy for metastatic breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34367
Abstract: The CDK4/6 inhibitor abemaciclib is a mainstay of treatment for hormone receptor–positive breast cancer. However, increased venous thromboembolism (VTE) rates in multiple clinical trials resulted in a black‐box warning for this agent. Thrombosis rates in… read more here.
Keywords: cancer venous; breast cancer; venous arterial; thrombosis ... See more keywords